Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1

Carcinogenesis
P BussW K Lutz

Abstract

Male F-344 rats were given [3H]aflatoxin B1 (AFB1) in the drinking water at three exposure levels (0.02, 0.6, 20 micrograms/l, resulting in average dose levels of 2.2, 73, 2110 ng/kg per day). After 4, 6 and 8 weeks, DNA was isolated from the livers and analyzed for aflatoxin-DNA adducts. The level of DNA adducts did not increase significantly after 4 weeks, indicating that a steady-state for adduct formation and removal had nearly been reached. At 8 weeks, the adduct levels were 0.91, 32 and 850 nucleotide-aflatoxin adducts per 10(9) nucleotides, i.e. clearly proportional to the dose. At the high dose level, a near 50% tumor incidence would be expected in a 2-year bioassay with F-344 rats while the low dose used is within the range of estimated human dietary exposures to aflatoxin in Western countries. The proportionality seen between exposure and steady-state DNA adduct level is discussed with respect to a linear extrapolation of the tumor risk to low dose.

Citations

Jan 1, 1996·International Archives of Occupational and Environmental Health·W K Lutz, T Fekete
Jan 1, 1991·Sozial- Und Präventivmedizin·W K Lutz
Mar 17, 2004·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·B C CupidR C Garner
Mar 5, 1999·Mutation Research·J S Wang, J D Groopman
Jan 26, 2012·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·Magda CarvajalMariano Guardado-Estrada
Jun 25, 2004·Molecular Biology of the Cell·Monika U Keller-SeitzMichael Fasullo
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·J G HengstlerF Oesch
Jul 17, 2008·Environmental Health Perspectives·Faisal F Y Radwan, John S Ramsdell
Mar 1, 1993·Environmental Health Perspectives·F A Beland, M C Poirier
Mar 1, 1993·Environmental Health Perspectives·J C HarrisonR C Garner
Oct 1, 1994·Environmental Health Perspectives·M C Poirier, F A Beland
Mar 1, 1996·Environmental Health Perspectives·G S BaileyJ D Hendricks
Aug 1, 1996·Drug and Chemical Toxicology·W N Choy
Mar 6, 2003·Human Mutation·Frank StaibCurtis C Harris
Nov 11, 2008·Mutation Research·Shareen H DoakGareth J S Jenkins
Mar 29, 2000·Environmental and Molecular Mutagenesis·D H PhillipsK W Turteltaub
Dec 13, 2016·Chemical Research in Toxicology·Alessia StornettaShana J Sturla
Jun 17, 2020·Archives of Toxicology·Andrea HartwigGerhard Eisenbrand
Jun 18, 2019·Dose-response : a Publication of International Hormesis Society·Kenneth T Bogen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.